ArticleFrontiers in pediatrics2025
Evaluation of phenol treatment for pilonidal sinus in adolescents.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Pilonidal sinus disease (PSD) is chronic condition predominantly affecting adolescents, often associated with risk factors such as obesity, poor hygiene, and prolonged sitting. Minimally invasive treatments like phenol procedure have gained attention as alternatives to traditional surgical methods due to their simplicity and potential for shorter recovery. This study aims to evaluate the efficacy and safety of phenol procedure in adolescents with pilonidal sinus, focusing on success rates, recurrence, and complications. Material and method: Total number of 28 adolescent patients with non-complicated PSD were included in this retrospective study. Results: This study included 28 adolescent patients (mean age: 15.04 ± 1.40 years), of which 60.7% were female. A total of 46.4% of the patients presented with a single sinus opening, while 53.6% had multiple sinus openings. Phenol procedure was administered with a mean of 3.32 ± 1.49 courses, resulting in complete healing in 75.0% of patients and an overall success rate of 82.1% after pre- or post-surgical procedure. Complications were observed in 14.3% of cases, while recurrence occurred in 21.4%. Persistent discharge was reported in 7.1% of patients, necessitating surgical excision. Conclusions: Our findings support that phenol treatment is a safe and effective minimally invasive approach for managing pilonidal sinus, demonstrating success rates comparable to conventional surgical methods. Furthermore, phenol procedure offers notable advantages, including preservation of tissue integrity, ease of implementation, and reduced recovery times, rendering it particularly advantageous for adolescent patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.